How to Read a Peptide Certificate of Analysis (HPLC & Mass Spec)

A peptide certificate of analysis is only useful if you can tell whether it actually describes the vial in front of you. Most COAs report two results, an HPLC purity percentage and a mass-spec identity check, and each answers a different question. This guide explains what those numbers mean, what they leave out, which impurities they can and cannot catch, and the red flags that should make you question a document. Worked examples use real molecular weights for BPC-157 and MOTS-c.

What is a peptide certificate of analysis?

A certificate of analysis (COA) is a batch-specific lab report stating what a sample was tested for, which methods were used, and what the results were. For a synthetic peptide, its core job is to establish identity (is this the right molecule?) and purity (how much of the detected material is that molecule?).

Because a synthetic peptide’s sequence is known in advance, analysis focuses on confirming identity and purity, and mass spectrometry with liquid chromatography is the standard toolset ^[1][2]. A complete COA usually contains:

• Header data: compound name, sequence or molecular formula, batch or lot number, test date, testing lab, and an approver.
• HPLC result: a purity percentage plus the chromatogram and peak table it came from.
• Mass spec result: theoretical mass, observed mass, and ideally the spectrum.
• Optional extras: net peptide content, water, counter-ions.

Impurities in synthetic peptides originate from starting materials, the manufacturing process, and storage conditions ^[3]. So a COA is a snapshot of one batch at one time, not a property of the compound. To see how batch-level documents are organized, browse an example COA library.

What does HPLC purity mean on a peptide COA?

HPLC purity is the area of the main peak expressed as a percentage of the total integrated peak area in a chromatogram, usually measured by UV absorbance. A result of 98% means 98% of the UV signal the method detected came from the main peak. It does not mean 98% of the powder by weight is the peptide.

Chromatogram basics

Reversed-phase HPLC, the usual method for peptides, separates molecules by hydrophobicity. The x-axis shows retention time in minutes; the y-axis shows detector response, typically UV absorbance near 214 to 220 nm, where peptide bonds absorb. The target peptide should appear as one dominant peak, with any related impurities as smaller peaks eluting before or after it. A usable chromatogram has labeled axes, a stated wavelength, method details, and a peak table with each peak’s retention time, area, and area percentage.

What HPLC purity does not show

• Identity. A clean single peak shows homogeneity, not that it is the right molecule.
• Net peptide content. Water, salts, and counter-ions are essentially invisible in the UV purity percentage.
• Co-eluting impurities. A modified peptide that elutes under the main peak inflates the number. Liquid chromatography with high-resolution mass spectrometry can quantify impurities even when they co-elute ^[4].
• Stereoisomers. A D-amino acid variant often elutes almost with the intended all-L form.
• Anything excluded by integration. A raised threshold or narrow window quietly drops small peaks.

Sensitive LC-HRMS methods can detect impurities below 0.1% of the main peptide ^[4], so a trace showing nothing but one peak is a prompt to ask about the method, not proof of perfection.

How does mass spectrometry verify a peptide’s identity?

Mass spectrometry measures the mass-to-charge ratio (m/z) of ionized molecules. If the observed mass matches the compound’s theoretical molecular weight within the instrument’s accuracy, the result supports identity; if it does not, the sample may be a different or modified molecule.

The molecular weight of a synthetic peptide can be determined readily and accurately by mass spectrometry ^[5]. Two details explain most apparent mismatches. First, there are two kinds of theoretical mass: the average molecular weight (what PubChem lists as molecular weight, based on natural isotope abundance) and the monoisotopic mass (all lightest isotopes, which high-resolution instruments report). Second, electrospray ionization (ESI) adds several protons, so a peptide of mass M appears at m/z = (M + n × 1.008) / n for charge state n. MALDI mostly produces singly charged [M+H]+ ions.

Worked example: expected ions for BPC-157 and MOTS-c

The table below uses PubChem masses. The ion values are our own arithmetic using the formula above. They are illustrative calculations, not measured spectra.

Compound	Formula	Average MW (PubChem)	Monoisotopic mass (PubChem)	Computed [M+H]+	Computed [M+2H]2+
BPC-157	C62H98N16O22	1419.5 g/mol	1418.704	1419.71	710.36 (mono); 710.76 (avg)
MOTS-c	C101H152N28O22S2	2174.6 g/mol	2174.111	2175.12	1088.06 (mono); 1088.31 (avg)

So an ESI spectrum of BPC-157 should show a doubly charged ion near m/z 710.36, and a MALDI spectrum a singly charged ion near m/z 1419.71. For MOTS-c, a triply charged ion would be expected near m/z 725.71 (computed, monoisotopic). The COA should state which ion it reports, or give a deconvoluted neutral mass that lands on the theoretical value.

Larger peptides spread across many charge states, so COAs usually report a deconvoluted mass. Tesamorelin (5136 g/mol) and retatrutide (4731 g/mol) fall in this range, and are best compared against average molecular weight. Metal complexes add another wrinkle: PubChem lists GHK-Cu as a copper complex of 402.92 g/mol, while the free GHK tripeptide is 340.38 g/mol, so a GHK-Cu COA should say which species its mass refers to.

Mass spec has limits too: ion intensity does not equal abundance, and isomers with identical mass cannot be told apart by mass alone.

What impurities can show up in a synthetic peptide?

The main impurity families are deletion and truncated sequences, oxidation, deamidation, stereoisomers from racemization, and non-peptide material such as TFA counter-ions and water. Each leaves a different fingerprint, and some are invisible to one method but obvious to another.

A “pure” peptide can carry many related species. LC-HRMS analysis of a thymalfasin pharmacopoeia standard separated and quantified 23 related impurities above 0.1 mg/g, including deamidation, succinimide, amino acid insertions and deletions, dimers, and isomers ^[6]. In a synthetic oxytocin material, 18 structurally related impurities totaled 31.1 mg/g ^[7].

Deletion and truncated sequences

A failed coupling step in solid-phase synthesis leaves a residue missing (deletion) or ends the chain early (truncation). These species are lighter than the target by the mass of the missing residue, roughly 57 Da for glycine or 97 Da for proline, and often elute close to the main peak. Incomplete removal of side-chain protecting groups produces the opposite case, heavier by-products, which tandem mass spectrometry can detect quickly ^[8].

Oxidation

Methionine oxidizes to methionine sulfoxide, adding about 16 Da per residue. MOTS-c (MRWQEMGYIFYPRKLR) contains two methionines and a tryptophan, so +16 and +32 Da species are worth looking for; on the doubly charged ion, each oxidation shifts the peak by about 8 m/z (computed). BPC-157 (GEPPPGKPADDAGLV) contains no methionine. Oxidations were among the 21 related impurities quantified in a synthetic oxytocin reference material ^[9].

Deamidation

Asparagine and glutamine can deamidate to aspartic and glutamic acid, a shift of only about +0.98 Da. That overlaps the natural isotope pattern, so high-resolution MS is usually needed. In thymalfasin, more than half of the related impurities arose directly or indirectly from a labile C-terminal asparagine ^[6].

Racemization and enantiomeric impurities

Unwanted D-isomers can enter as impurities in amino acid starting materials, form during synthesis, and in some cases form during shelf life ^[10]. They have the same mass as the intended peptide, so only chiral methods reveal them. Peptide epimers are one of the specific characterization challenges highlighted in LC-MS reviews ^[3].

Counter-ions, TFA, and net peptide content

Trifluoroacetic acid (TFA) is used in peptide cleavage and purification, so many research peptides are TFA salts; PubChem even lists a “MOTS-c (human) (trifluoroacetate salt)” synonym. Counter-ions and water add weight without adding peptide. A mass-balance study of synthetic glucagon measured water (Karl Fischer titration), TFA (ion chromatography), and inorganic ions (ICP-MS), then subtracted all impurities to assign 896.36 mg/g of glucagon ^[11]. A synthetic oxytocin material was assigned 796.5 mg/g by the same approach ^[9]. High HPLC purity and much lower net peptide content can both be true of one vial.

Impurity type	Mass change vs. target	Seen by HPLC area %?	Seen by MS?
Deletion / truncation	Minus the missing residue(s), e.g. about −57 Da for Gly	Usually, as a nearby peak	Yes
Incomplete deprotection	Plus the protecting group	Usually	Yes
Methionine oxidation	About +16 Da per residue	Often, as a shifted peak	Yes
Deamidation	About +0.98 Da	Sometimes co-elutes	High-resolution MS needed
Racemization (D-isomer)	None	Often co-elutes	No; needs chiral methods
TFA, water, salts	Not part of the peptide	No	No; needs ion chromatography, Karl Fischer

What are the red flags on a peptide COA?

The biggest red flags are missing traceability (no batch number, lab name, or date), documents that do not match the vial, recycled chromatograms, and an observed mass that does not match the compound’s molecular weight. Any one breaks the link between paper and product.

Reviews of falsified peptide and protein products describe the wrong active ingredient, the wrong amount, or none at all ^[12]. Watch for:

• No batch or lot number. The report cannot be tied to any production run.
• Batch mismatch. The lot on the COA differs from the lot printed on the vial label.
• Generic or reused chromatograms. Identical peaks and baseline noise across different batches or compounds.
• No lab name, test date, or method. An anonymous, undated report with no column, gradient, or wavelength cannot be checked.
• Mass that does not match. The observed value falls far outside the expected ions, matches a different compound, or is replaced by the word “conforms” with no number.
• Purity without evidence. A percentage with no chromatogram or peak table, or a cropped trace.
• Purity presented as content. HPLC area % is described as the amount of peptide in the vial.

What should a peptide COA checklist include?

A good checklist covers traceability, identity, purity, and composition, each answerable from the document itself.

Check	What good looks like	Red flag
Batch / lot number	Present and identical to the vial label	Missing or mismatched
Lab and date	Named lab, test date, approver	Anonymous or undated
Compound identity	Name plus sequence or molecular formula	Name only
Theoretical mass	Matches PubChem, e.g. BPC-157 1419.5, MOTS-c 2174.6 g/mol	Absent or wrong
Observed mass	Value given, ion or charge state labeled, within instrument accuracy	“Conforms” with no number
Chromatogram	Labeled axes, wavelength, method, peak table	Image only, cropped, unreadable
Purity %	Consistent with the peak table areas	Number with no trace behind it
Batch uniqueness	Distinct trace for each batch	Same trace on several products
Net peptide content	Stated, or clearly marked as not tested	HPLC purity presented as content
Impurity notes	Major related impurities identified where tested	Unexplained extra peaks

Bottom line

A trustworthy peptide COA ties a named lab, a test date, and a batch number to the exact vial you hold. Its mass spec result should land on the compound’s theoretical mass, such as 1419.5 g/mol for BPC-157, with the ion or charge state stated. Its HPLC purity should come with a readable chromatogram and peak table. Remember that purity is not net peptide content, and that neither method alone catches every impurity.